Wind Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Wind Bio General Information

Description

Developer of recombinant protein and antibody engineering technology designed to support diagnostic and therapeutic applications. The company offers recombinant protein expression and purification, monoclonal antibody development through hybridoma methods, antibody humanization techniques, and immunological diagnostic assays, and emphasizes accuracy, scalability, and adaptability, enabling biotechnology firms, pharmaceutical companies, and healthcare providers to access reliable biomolecular tools, advance diagnostic capabilities, improve therapeutic development, reduce dependency on conventional methods, and establish robust platforms for clinical and research use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 101-1, Phase 2, KNU Startup Cube
  • 1 Gangwondaehak-gil
  • Chuncheon, Gangwon
  • South Korea
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Room 101-1, Phase 2, KNU Startup Cube
  • 1 Gangwondaehak-gil
  • Chuncheon, Gangwon
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wind Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jun-2026 Completed Pre-Clinical Trials
To view Wind Bio’s complete valuation and funding history, request access »

Wind Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wind Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
C&Venture Partners Venture Capital Minority
To view Wind Bio’s complete investors history, request access »

Wind Bio FAQs

  • When was Wind Bio founded?

    Wind Bio was founded in 2020.

  • Where is Wind Bio headquartered?

    Wind Bio is headquartered in Chuncheon, South Korea.

  • What is the size of Wind Bio?

    Wind Bio has 5 total employees.

  • What industry is Wind Bio in?

    Wind Bio’s primary industry is Biotechnology.

  • Is Wind Bio a private or public company?

    Wind Bio is a Private company.

  • What is Wind Bio’s current revenue?

    The current revenue for Wind Bio is .

  • Who are Wind Bio’s investors?

    C&Venture Partners has invested in Wind Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process